HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krzysztof Zmudka Selected Research

C-Reactive Protein

12/2017Determinants of long-term outcome in patients after percutaneous stent-assisted management of symptomatic subclavian or innominate artery stenosis or occlusion.
3/2010The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis.
8/2007Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krzysztof Zmudka Research Topics

Disease

30ST Elevation Myocardial Infarction
01/2018 - 01/2004
23Myocardial Infarction
04/2020 - 01/2002
13Infarction (Infarctions)
01/2018 - 01/2002
8Thrombosis (Thrombus)
04/2020 - 08/2006
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2012 - 02/2002
7Hemorrhage
04/2020 - 09/2004
7Acute Coronary Syndrome
08/2011 - 05/2003
6Pathologic Constriction (Stenosis)
12/2017 - 10/2002
4Stroke (Strokes)
01/2018 - 08/2004
4Atherosclerosis
12/2017 - 08/2007
4Pain (Aches)
11/2010 - 01/2008
4Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 05/2003
4Cardiogenic Shock
08/2006 - 01/2004
4Atrial Heart Septal Defects (Atrial Septal Defect)
09/2004 - 01/2004
3Heart Failure
04/2022 - 09/2004
3Inflammation (Inflammations)
10/2013 - 01/2008
3Shock
10/2010 - 01/2004
3Stable Angina
02/2008 - 05/2003
2Carotid Stenosis (Carotid Artery Stenosis)
08/2016 - 10/2002
2Hypertension (High Blood Pressure)
01/2014 - 08/2007
2Ventricular Remodeling
10/2013 - 03/2007
2Ischemia
08/2012 - 09/2004
2Vascular System Injuries
05/2010 - 06/2009
2Chest Pain (Chest Pains)
03/2010 - 11/2005
2Peripheral Arterial Disease
06/2009 - 02/2007
1Aortic Valve Stenosis (Aortic Stenosis)
04/2022
1Ischemic Stroke
12/2017
1Fibrosis (Cirrhosis)
10/2013
1Aneurysm (Aneurysms)
10/2013
1Hypercholesterolemia
10/2013
1Out-of-Hospital Cardiac Arrest
03/2012
1Chronic Kidney Failure (Chronic Renal Failure)
09/2010
1Chronic Renal Insufficiency
09/2010
1Type 2 Diabetes Mellitus (MODY)
08/2008
1Hyperglycemia
08/2008

Drug/Important Bio-Agent (IBA)

12Abciximab (ReoPro)FDA Link
01/2012 - 01/2002
6ThrombinFDA Link
08/2011 - 08/2006
5Biomarkers (Surrogate Marker)IBA
01/2014 - 01/2009
5omega-Chloroacetophenone (Mace)IBA
01/2014 - 03/2004
5FibrinIBA
09/2010 - 10/2007
4N(2)-(3-trifluoromethylphenyl)guanineIBA
02/2011 - 10/2004
4Tissue Plasminogen Activator (Alteplase)FDA Link
03/2010 - 01/2002
3C-Reactive ProteinIBA
12/2017 - 08/2007
3Paclitaxel (Taxol)FDA LinkGeneric
02/2013 - 11/2005
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2009 - 01/2007
3Heparin (Liquaemin)FDA LinkGeneric
02/2008 - 11/2005
2Troponin T (Troponin T1)IBA
01/2018 - 01/2015
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 01/2004
2fibrin fragment D (D-dimer)IBA
01/2014 - 02/2013
2Brain Natriuretic Peptide (Natrecor)FDA Link
10/2013 - 08/2006
2pro-brain natriuretic peptide (1-76)IBA
10/2013 - 08/2006
2Troponin IIBA
03/2013 - 01/2009
2Simvastatin (Zocor)FDA LinkGeneric
08/2011 - 05/2010
2Plasminogen Activators (Plasminogen Activator)IBA
08/2011 - 08/2006
2PolymersIBA
11/2010 - 11/2005
2Clopidogrel (Plavix)FDA Link
10/2010 - 06/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2010 - 01/2007
2reteplaseFDA Link
02/2008 - 09/2004
2S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
10/2007 - 09/2004
2Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2006 - 03/2006
2Pharmaceutical PreparationsIBA
08/2006 - 01/2006
2Platelet Membrane Glycoprotein IIbIBA
01/2004 - 05/2003
1amsonic acid (DAS)IBA
04/2022
1TicagrelorIBA
04/2020
1Oxygen (Dioxygen)IBA
01/2018
1Aligeron (AS 2)IBA
08/2016
1Metalloproteases (Metalloproteinases)IBA
10/2013
1NADPH Oxidases (NAD(P)H oxidase)IBA
10/2013
1Superoxides (Superoxide)IBA
10/2013
1GadoliniumIBA
03/2013
1Cystatin CIBA
02/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2012
1Interleukin-6 (Interleukin 6)IBA
08/2012
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2012
1ProstaglandinsIBA
08/2011
1Prothrombin (Factor II)IBA
08/2011
1Thromboxane B2IBA
08/2011
1AntithrombinsIBA
08/2011
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
08/2011
1CD40 Ligand (CD40L)IBA
08/2011
1Ezetimibe (Zetia)FDA Link
08/2011
1MetalsIBA
11/2010
1LipidsIBA
01/2010
1P-SelectinIBA
06/2009
1N 30IBA
06/2009
1Proteins (Proteins, Gene)FDA Link
01/2009

Therapy/Procedure

25Percutaneous Coronary Intervention
01/2015 - 01/2002
20Stents
04/2020 - 10/2002
11Therapeutics
02/2012 - 01/2002
4Catheters
01/2014 - 01/2003
4Septal Occluder Device
09/2004 - 01/2004
3Thrombolytic Therapy
02/2008 - 09/2004
2Patient Readmission
01/2018 - 09/2004
1Denervation
01/2014
1Sympathectomy (Sympathectomies)
01/2014
1Transplantation
03/2013
1Drug-Eluting Stents
08/2012
1Embolic Protection Devices
02/2012
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2010
1Thrombectomy
11/2010